nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—CYP2B6—Thiotepa—urinary bladder cancer	0.157	0.448	CbGbCtD
Isoflurane—ALB—Fluorouracil—urinary bladder cancer	0.05	0.143	CbGbCtD
Isoflurane—CYP2B6—Cisplatin—urinary bladder cancer	0.0433	0.124	CbGbCtD
Isoflurane—CYP2E1—Etoposide—urinary bladder cancer	0.0432	0.123	CbGbCtD
Isoflurane—CYP2B6—Doxorubicin—urinary bladder cancer	0.029	0.0829	CbGbCtD
Isoflurane—ALB—Methotrexate—urinary bladder cancer	0.0276	0.0787	CbGbCtD
Isoflurane—KCNK2—prostate gland—urinary bladder cancer	0.0106	0.0415	CbGeAlD
Isoflurane—GLRB—prostate gland—urinary bladder cancer	0.00889	0.0348	CbGeAlD
Isoflurane—Necrosis—Mitomycin—urinary bladder cancer	0.00878	0.0415	CcSEcCtD
Isoflurane—Shivering—Gemcitabine—urinary bladder cancer	0.00782	0.037	CcSEcCtD
Isoflurane—KCNK10—renal system—urinary bladder cancer	0.00774	0.0303	CbGeAlD
Isoflurane—ND1—prostate gland—urinary bladder cancer	0.00711	0.0278	CbGeAlD
Isoflurane—KCNK3—renal system—urinary bladder cancer	0.00699	0.0273	CbGeAlD
Isoflurane—CYP2E1—urine—urinary bladder cancer	0.00636	0.0249	CbGeAlD
Isoflurane—ATP5D—prostate gland—urinary bladder cancer	0.00573	0.0224	CbGeAlD
Isoflurane—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00566	0.0268	CcSEcCtD
Isoflurane—ATP2C1—prostate gland—urinary bladder cancer	0.00565	0.0221	CbGeAlD
Isoflurane—KCNK3—female reproductive system—urinary bladder cancer	0.0056	0.0219	CbGeAlD
Isoflurane—GABRP—prostate gland—urinary bladder cancer	0.00554	0.0217	CbGeAlD
Isoflurane—KCNK2—vagina—urinary bladder cancer	0.00524	0.0205	CbGeAlD
Isoflurane—ND1—smooth muscle tissue—urinary bladder cancer	0.00503	0.0197	CbGeAlD
Isoflurane—Ileus—Thiotepa—urinary bladder cancer	0.00489	0.0232	CcSEcCtD
Isoflurane—ATP5D—seminal vesicle—urinary bladder cancer	0.00485	0.0189	CbGeAlD
Isoflurane—ND1—renal system—urinary bladder cancer	0.00484	0.0189	CbGeAlD
Isoflurane—ATP2C1—seminal vesicle—urinary bladder cancer	0.00478	0.0187	CbGeAlD
Isoflurane—GLRB—vagina—urinary bladder cancer	0.00439	0.0172	CbGeAlD
Isoflurane—GABRE—prostate gland—urinary bladder cancer	0.00423	0.0165	CbGeAlD
Isoflurane—CALM3—prostate gland—urinary bladder cancer	0.00416	0.0163	CbGeAlD
Isoflurane—ATP5D—smooth muscle tissue—urinary bladder cancer	0.00406	0.0159	CbGeAlD
Isoflurane—Delirium—Thiotepa—urinary bladder cancer	0.00403	0.0191	CcSEcCtD
Isoflurane—ATP2C1—smooth muscle tissue—urinary bladder cancer	0.004	0.0157	CbGeAlD
Isoflurane—ATP5D—renal system—urinary bladder cancer	0.0039	0.0153	CbGeAlD
Isoflurane—ND1—female reproductive system—urinary bladder cancer	0.00388	0.0152	CbGeAlD
Isoflurane—ATP2C1—renal system—urinary bladder cancer	0.00385	0.0151	CbGeAlD
Isoflurane—ATP5D—urethra—urinary bladder cancer	0.00384	0.015	CbGeAlD
Isoflurane—ATP2C1—urethra—urinary bladder cancer	0.00379	0.0148	CbGeAlD
Isoflurane—GABRP—urethra—urinary bladder cancer	0.00371	0.0145	CbGeAlD
Isoflurane—Necrosis—Fluorouracil—urinary bladder cancer	0.00365	0.0173	CcSEcCtD
Isoflurane—GABRB3—prostate gland—urinary bladder cancer	0.00359	0.014	CbGeAlD
Isoflurane—GABRE—seminal vesicle—urinary bladder cancer	0.00358	0.014	CbGeAlD
Isoflurane—CALM3—seminal vesicle—urinary bladder cancer	0.00352	0.0138	CbGeAlD
Isoflurane—Necrosis—Cisplatin—urinary bladder cancer	0.00346	0.0164	CcSEcCtD
Isoflurane—KCNK2—lymph node—urinary bladder cancer	0.00339	0.0133	CbGeAlD
Isoflurane—Laryngospasm—Etoposide—urinary bladder cancer	0.00333	0.0158	CcSEcCtD
Isoflurane—CALM2—prostate gland—urinary bladder cancer	0.00327	0.0128	CbGeAlD
Isoflurane—CALM1—prostate gland—urinary bladder cancer	0.00326	0.0127	CbGeAlD
Isoflurane—Liver injury—Cisplatin—urinary bladder cancer	0.00323	0.0153	CcSEcCtD
Isoflurane—Necrosis—Etoposide—urinary bladder cancer	0.00317	0.015	CcSEcCtD
Isoflurane—ATP5D—female reproductive system—urinary bladder cancer	0.00313	0.0122	CbGeAlD
Isoflurane—ATP2C1—female reproductive system—urinary bladder cancer	0.00309	0.0121	CbGeAlD
Isoflurane—GABRB1—vagina—urinary bladder cancer	0.00305	0.0119	CbGeAlD
Isoflurane—GABRP—female reproductive system—urinary bladder cancer	0.00303	0.0118	CbGeAlD
Isoflurane—CALM3—smooth muscle tissue—urinary bladder cancer	0.00295	0.0115	CbGeAlD
Isoflurane—GLRB—lymph node—urinary bladder cancer	0.00284	0.0111	CbGeAlD
Isoflurane—GABRE—urethra—urinary bladder cancer	0.00283	0.0111	CbGeAlD
Isoflurane—ATP5D—vagina—urinary bladder cancer	0.00283	0.0111	CbGeAlD
Isoflurane—Body temperature increased—Valrubicin—urinary bladder cancer	0.00282	0.0133	CcSEcCtD
Isoflurane—Hepatic failure—Thiotepa—urinary bladder cancer	0.0028	0.0132	CcSEcCtD
Isoflurane—ATP2C1—vagina—urinary bladder cancer	0.00279	0.0109	CbGeAlD
Isoflurane—CALM3—urethra—urinary bladder cancer	0.00279	0.0109	CbGeAlD
Isoflurane—CALM2—seminal vesicle—urinary bladder cancer	0.00277	0.0108	CbGeAlD
Isoflurane—GABRP—vagina—urinary bladder cancer	0.00274	0.0107	CbGeAlD
Isoflurane—Hiccups—Cisplatin—urinary bladder cancer	0.00272	0.0129	CcSEcCtD
Isoflurane—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.00272	0.0129	CcSEcCtD
Isoflurane—Hyperkalaemia—Cisplatin—urinary bladder cancer	0.00267	0.0126	CcSEcCtD
Isoflurane—Cough—Mitomycin—urinary bladder cancer	0.00263	0.0124	CcSEcCtD
Isoflurane—Body temperature increased—Carboplatin—urinary bladder cancer	0.00261	0.0124	CcSEcCtD
Isoflurane—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.00242	0.0115	CcSEcCtD
Isoflurane—CALM2—epithelium—urinary bladder cancer	0.0024	0.0094	CbGeAlD
Isoflurane—CALM1—epithelium—urinary bladder cancer	0.00239	0.00935	CbGeAlD
Isoflurane—Cardiac arrest—Thiotepa—urinary bladder cancer	0.00239	0.0113	CcSEcCtD
Isoflurane—Hepatic failure—Gemcitabine—urinary bladder cancer	0.00235	0.0111	CcSEcCtD
Isoflurane—CALM2—smooth muscle tissue—urinary bladder cancer	0.00232	0.00905	CbGeAlD
Isoflurane—GABRE—female reproductive system—urinary bladder cancer	0.00231	0.00903	CbGeAlD
Isoflurane—CALM1—smooth muscle tissue—urinary bladder cancer	0.00231	0.00901	CbGeAlD
Isoflurane—CYP2E1—prostate gland—urinary bladder cancer	0.00228	0.00892	CbGeAlD
Isoflurane—ND1—lymph node—urinary bladder cancer	0.00227	0.00887	CbGeAlD
Isoflurane—Vomiting—Valrubicin—urinary bladder cancer	0.00227	0.0107	CcSEcCtD
Isoflurane—Rash—Valrubicin—urinary bladder cancer	0.00225	0.0106	CcSEcCtD
Isoflurane—Dermatitis—Valrubicin—urinary bladder cancer	0.00225	0.0106	CcSEcCtD
Isoflurane—CALM2—renal system—urinary bladder cancer	0.00223	0.00872	CbGeAlD
Isoflurane—CALM1—renal system—urinary bladder cancer	0.00222	0.00868	CbGeAlD
Isoflurane—CALM2—urethra—urinary bladder cancer	0.00219	0.00856	CbGeAlD
Isoflurane—CALM1—urethra—urinary bladder cancer	0.00218	0.00852	CbGeAlD
Isoflurane—Nausea—Valrubicin—urinary bladder cancer	0.00212	0.01	CcSEcCtD
Isoflurane—GABRA2—vagina—urinary bladder cancer	0.00211	0.00824	CbGeAlD
Isoflurane—GABRE—vagina—urinary bladder cancer	0.00209	0.00817	CbGeAlD
Isoflurane—CALM3—vagina—urinary bladder cancer	0.00206	0.00804	CbGeAlD
Isoflurane—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00198	0.00936	CcSEcCtD
Isoflurane—Ileus—Epirubicin—urinary bladder cancer	0.00197	0.00932	CcSEcCtD
Isoflurane—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00196	0.00928	CcSEcCtD
Isoflurane—GABRB3—female reproductive system—urinary bladder cancer	0.00196	0.00765	CbGeAlD
Isoflurane—Body temperature increased—Mitomycin—urinary bladder cancer	0.00194	0.00919	CcSEcCtD
Isoflurane—CYP2E1—seminal vesicle—urinary bladder cancer	0.00193	0.00755	CbGeAlD
Isoflurane—Necrosis—Methotrexate—urinary bladder cancer	0.0019	0.00898	CcSEcCtD
Isoflurane—Jaundice—Thiotepa—urinary bladder cancer	0.00189	0.00894	CcSEcCtD
Isoflurane—Ventricular arrhythmia—Epirubicin—urinary bladder cancer	0.00188	0.00892	CcSEcCtD
Isoflurane—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00183	0.00867	CcSEcCtD
Isoflurane—ATP5D—lymph node—urinary bladder cancer	0.00183	0.00715	CbGeAlD
Isoflurane—Ileus—Doxorubicin—urinary bladder cancer	0.00182	0.00863	CcSEcCtD
Isoflurane—ATP2C1—lymph node—urinary bladder cancer	0.00181	0.00706	CbGeAlD
Isoflurane—Bronchospasm—Gemcitabine—urinary bladder cancer	0.0018	0.00851	CcSEcCtD
Isoflurane—CALM2—female reproductive system—urinary bladder cancer	0.00179	0.00698	CbGeAlD
Isoflurane—Necrosis—Epirubicin—urinary bladder cancer	0.00178	0.00841	CcSEcCtD
Isoflurane—CALM1—female reproductive system—urinary bladder cancer	0.00178	0.00695	CbGeAlD
Isoflurane—Ventricular arrhythmia—Doxorubicin—urinary bladder cancer	0.00174	0.00825	CcSEcCtD
Isoflurane—Hallucination—Thiotepa—urinary bladder cancer	0.00173	0.00819	CcSEcCtD
Isoflurane—Cardiac arrest—Etoposide—urinary bladder cancer	0.00172	0.00813	CcSEcCtD
Isoflurane—Liver injury—Epirubicin—urinary bladder cancer	0.00166	0.00784	CcSEcCtD
Isoflurane—CYP2B6—renal system—urinary bladder cancer	0.00166	0.00648	CbGeAlD
Isoflurane—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00165	0.0078	CcSEcCtD
Isoflurane—Necrosis—Doxorubicin—urinary bladder cancer	0.00164	0.00778	CcSEcCtD
Isoflurane—Delirium—Epirubicin—urinary bladder cancer	0.00162	0.00767	CcSEcCtD
Isoflurane—CALM2—vagina—urinary bladder cancer	0.00161	0.00631	CbGeAlD
Isoflurane—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00161	0.00764	CcSEcCtD
Isoflurane—CALM1—vagina—urinary bladder cancer	0.00161	0.00628	CbGeAlD
Isoflurane—Vomiting—Mitomycin—urinary bladder cancer	0.00156	0.00739	CcSEcCtD
Isoflurane—Chills—Thiotepa—urinary bladder cancer	0.00156	0.00739	CcSEcCtD
Isoflurane—CYP2E1—renal system—urinary bladder cancer	0.00156	0.00608	CbGeAlD
Isoflurane—Arrhythmia—Thiotepa—urinary bladder cancer	0.00155	0.00735	CcSEcCtD
Isoflurane—Rash—Mitomycin—urinary bladder cancer	0.00155	0.00733	CcSEcCtD
Isoflurane—Dermatitis—Mitomycin—urinary bladder cancer	0.00155	0.00732	CcSEcCtD
Isoflurane—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00154	0.00729	CcSEcCtD
Isoflurane—Bronchospasm—Etoposide—urinary bladder cancer	0.00154	0.00727	CcSEcCtD
Isoflurane—Liver injury—Doxorubicin—urinary bladder cancer	0.00153	0.00726	CcSEcCtD
Isoflurane—CYP2E1—urethra—urinary bladder cancer	0.00153	0.00597	CbGeAlD
Isoflurane—Delirium—Doxorubicin—urinary bladder cancer	0.0015	0.0071	CcSEcCtD
Isoflurane—Nausea—Mitomycin—urinary bladder cancer	0.00146	0.00691	CcSEcCtD
Isoflurane—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00144	0.0068	CcSEcCtD
Isoflurane—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00139	0.0066	CcSEcCtD
Isoflurane—Hiccups—Epirubicin—urinary bladder cancer	0.00139	0.0066	CcSEcCtD
Isoflurane—Agitation—Thiotepa—urinary bladder cancer	0.00139	0.00658	CcSEcCtD
Isoflurane—Hyperkalaemia—Epirubicin—urinary bladder cancer	0.00137	0.00648	CcSEcCtD
Isoflurane—GABRA2—lymph node—urinary bladder cancer	0.00136	0.00533	CbGeAlD
Isoflurane—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00136	0.00643	CcSEcCtD
Isoflurane—Jaundice—Etoposide—urinary bladder cancer	0.00136	0.00642	CcSEcCtD
Isoflurane—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00135	0.00641	CcSEcCtD
Isoflurane—GABRE—lymph node—urinary bladder cancer	0.00135	0.00528	CbGeAlD
Isoflurane—CALM3—lymph node—urinary bladder cancer	0.00133	0.0052	CbGeAlD
Isoflurane—CYP2B6—female reproductive system—urinary bladder cancer	0.00133	0.00519	CbGeAlD
Isoflurane—Cough—Thiotepa—urinary bladder cancer	0.00132	0.00625	CcSEcCtD
Isoflurane—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00132	0.00623	CcSEcCtD
Isoflurane—Chills—Gemcitabine—urinary bladder cancer	0.00131	0.00621	CcSEcCtD
Isoflurane—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00131	0.00619	CcSEcCtD
Isoflurane—Hiccups—Doxorubicin—urinary bladder cancer	0.00129	0.00611	CcSEcCtD
Isoflurane—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00129	0.00611	CcSEcCtD
Isoflurane—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00129	0.00608	CcSEcCtD
Isoflurane—Hyperkalaemia—Doxorubicin—urinary bladder cancer	0.00127	0.006	CcSEcCtD
Isoflurane—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00127	0.00599	CcSEcCtD
Isoflurane—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00125	0.00593	CcSEcCtD
Isoflurane—CYP2E1—female reproductive system—urinary bladder cancer	0.00125	0.00487	CbGeAlD
Isoflurane—ALB—lymph node—urinary bladder cancer	0.00123	0.00482	CbGeAlD
Isoflurane—Arrhythmia—Cisplatin—urinary bladder cancer	0.00122	0.00577	CcSEcCtD
Isoflurane—Hepatic failure—Methotrexate—urinary bladder cancer	0.0012	0.0057	CcSEcCtD
Isoflurane—CYP2B6—vagina—urinary bladder cancer	0.0012	0.00469	CbGeAlD
Isoflurane—Cardiac disorder—Etoposide—urinary bladder cancer	0.00116	0.00549	CcSEcCtD
Isoflurane—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00116	0.00548	CcSEcCtD
Isoflurane—Hepatic failure—Epirubicin—urinary bladder cancer	0.00113	0.00533	CcSEcCtD
Isoflurane—Chills—Etoposide—urinary bladder cancer	0.00112	0.0053	CcSEcCtD
Isoflurane—Cough—Gemcitabine—urinary bladder cancer	0.00111	0.00526	CcSEcCtD
Isoflurane—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00107	0.00507	CcSEcCtD
Isoflurane—CALM2—lymph node—urinary bladder cancer	0.00104	0.00408	CbGeAlD
Isoflurane—Hepatic failure—Doxorubicin—urinary bladder cancer	0.00104	0.00493	CcSEcCtD
Isoflurane—CALM1—lymph node—urinary bladder cancer	0.00104	0.00406	CbGeAlD
Isoflurane—Body temperature increased—Thiotepa—urinary bladder cancer	0.000977	0.00462	CcSEcCtD
Isoflurane—Hypotension—Gemcitabine—urinary bladder cancer	0.000971	0.0046	CcSEcCtD
Isoflurane—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000963	0.00456	CcSEcCtD
Isoflurane—Hypotension—Fluorouracil—urinary bladder cancer	0.000955	0.00452	CcSEcCtD
Isoflurane—Cough—Etoposide—urinary bladder cancer	0.000949	0.00449	CcSEcCtD
Isoflurane—Hypotension—Cisplatin—urinary bladder cancer	0.000906	0.00428	CcSEcCtD
Isoflurane—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000891	0.00421	CcSEcCtD
Isoflurane—Hypotension—Etoposide—urinary bladder cancer	0.00083	0.00392	CcSEcCtD
Isoflurane—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000822	0.00389	CcSEcCtD
Isoflurane—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000808	0.00382	CcSEcCtD
Isoflurane—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000789	0.00373	CcSEcCtD
Isoflurane—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000789	0.00373	CcSEcCtD
Isoflurane—Vomiting—Thiotepa—urinary bladder cancer	0.000786	0.00372	CcSEcCtD
Isoflurane—Rash—Thiotepa—urinary bladder cancer	0.000779	0.00369	CcSEcCtD
Isoflurane—Dermatitis—Thiotepa—urinary bladder cancer	0.000779	0.00368	CcSEcCtD
Isoflurane—Body temperature increased—Cisplatin—urinary bladder cancer	0.000766	0.00362	CcSEcCtD
Isoflurane—Jaundice—Epirubicin—urinary bladder cancer	0.000761	0.0036	CcSEcCtD
Isoflurane—Hepatitis—Methotrexate—urinary bladder cancer	0.000748	0.00354	CcSEcCtD
Isoflurane—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000738	0.00349	CcSEcCtD
Isoflurane—Nausea—Thiotepa—urinary bladder cancer	0.000734	0.00347	CcSEcCtD
Isoflurane—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00073	0.00346	CcSEcCtD
Isoflurane—Jaundice—Doxorubicin—urinary bladder cancer	0.000704	0.00333	CcSEcCtD
Isoflurane—Body temperature increased—Etoposide—urinary bladder cancer	0.000702	0.00332	CcSEcCtD
Isoflurane—Hepatitis—Epirubicin—urinary bladder cancer	0.0007	0.00331	CcSEcCtD
Isoflurane—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000695	0.00329	CcSEcCtD
Isoflurane—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000683	0.00323	CcSEcCtD
Isoflurane—Chills—Methotrexate—urinary bladder cancer	0.000672	0.00318	CcSEcCtD
Isoflurane—Vomiting—Gemcitabine—urinary bladder cancer	0.000661	0.00313	CcSEcCtD
Isoflurane—Rash—Gemcitabine—urinary bladder cancer	0.000656	0.0031	CcSEcCtD
Isoflurane—Dermatitis—Gemcitabine—urinary bladder cancer	0.000655	0.0031	CcSEcCtD
Isoflurane—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00065	0.00308	CcSEcCtD
Isoflurane—Vomiting—Fluorouracil—urinary bladder cancer	0.00065	0.00308	CcSEcCtD
Isoflurane—Hepatitis—Doxorubicin—urinary bladder cancer	0.000648	0.00307	CcSEcCtD
Isoflurane—Rash—Fluorouracil—urinary bladder cancer	0.000645	0.00305	CcSEcCtD
Isoflurane—Dermatitis—Fluorouracil—urinary bladder cancer	0.000644	0.00305	CcSEcCtD
Isoflurane—Chills—Epirubicin—urinary bladder cancer	0.000628	0.00297	CcSEcCtD
Isoflurane—Arrhythmia—Epirubicin—urinary bladder cancer	0.000626	0.00296	CcSEcCtD
Isoflurane—Nausea—Gemcitabine—urinary bladder cancer	0.000618	0.00292	CcSEcCtD
Isoflurane—Vomiting—Cisplatin—urinary bladder cancer	0.000616	0.00292	CcSEcCtD
Isoflurane—Rash—Cisplatin—urinary bladder cancer	0.000611	0.00289	CcSEcCtD
Isoflurane—Dermatitis—Cisplatin—urinary bladder cancer	0.00061	0.00289	CcSEcCtD
Isoflurane—Nausea—Fluorouracil—urinary bladder cancer	0.000607	0.00287	CcSEcCtD
Isoflurane—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000601	0.00285	CcSEcCtD
Isoflurane—Chills—Doxorubicin—urinary bladder cancer	0.000582	0.00275	CcSEcCtD
Isoflurane—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000579	0.00274	CcSEcCtD
Isoflurane—Nausea—Cisplatin—urinary bladder cancer	0.000576	0.00272	CcSEcCtD
Isoflurane—Cough—Methotrexate—urinary bladder cancer	0.000569	0.00269	CcSEcCtD
Isoflurane—Vomiting—Etoposide—urinary bladder cancer	0.000564	0.00267	CcSEcCtD
Isoflurane—Agitation—Epirubicin—urinary bladder cancer	0.00056	0.00265	CcSEcCtD
Isoflurane—Rash—Etoposide—urinary bladder cancer	0.00056	0.00265	CcSEcCtD
Isoflurane—Dermatitis—Etoposide—urinary bladder cancer	0.000559	0.00265	CcSEcCtD
Isoflurane—Cough—Epirubicin—urinary bladder cancer	0.000532	0.00252	CcSEcCtD
Isoflurane—Nausea—Etoposide—urinary bladder cancer	0.000527	0.00249	CcSEcCtD
Isoflurane—Agitation—Doxorubicin—urinary bladder cancer	0.000518	0.00245	CcSEcCtD
Isoflurane—Hypotension—Methotrexate—urinary bladder cancer	0.000497	0.00235	CcSEcCtD
Isoflurane—Cough—Doxorubicin—urinary bladder cancer	0.000492	0.00233	CcSEcCtD
Isoflurane—Hypotension—Epirubicin—urinary bladder cancer	0.000465	0.0022	CcSEcCtD
Isoflurane—Hypotension—Doxorubicin—urinary bladder cancer	0.00043	0.00204	CcSEcCtD
Isoflurane—Body temperature increased—Methotrexate—urinary bladder cancer	0.00042	0.00199	CcSEcCtD
Isoflurane—Body temperature increased—Epirubicin—urinary bladder cancer	0.000393	0.00186	CcSEcCtD
Isoflurane—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000364	0.00172	CcSEcCtD
Isoflurane—Vomiting—Methotrexate—urinary bladder cancer	0.000338	0.0016	CcSEcCtD
Isoflurane—Rash—Methotrexate—urinary bladder cancer	0.000335	0.00159	CcSEcCtD
Isoflurane—Dermatitis—Methotrexate—urinary bladder cancer	0.000335	0.00158	CcSEcCtD
Isoflurane—Vomiting—Epirubicin—urinary bladder cancer	0.000316	0.0015	CcSEcCtD
Isoflurane—Nausea—Methotrexate—urinary bladder cancer	0.000316	0.00149	CcSEcCtD
Isoflurane—Rash—Epirubicin—urinary bladder cancer	0.000314	0.00148	CcSEcCtD
Isoflurane—Dermatitis—Epirubicin—urinary bladder cancer	0.000313	0.00148	CcSEcCtD
Isoflurane—Nausea—Epirubicin—urinary bladder cancer	0.000296	0.0014	CcSEcCtD
Isoflurane—Vomiting—Doxorubicin—urinary bladder cancer	0.000293	0.00139	CcSEcCtD
Isoflurane—Rash—Doxorubicin—urinary bladder cancer	0.00029	0.00137	CcSEcCtD
Isoflurane—Dermatitis—Doxorubicin—urinary bladder cancer	0.00029	0.00137	CcSEcCtD
Isoflurane—Nausea—Doxorubicin—urinary bladder cancer	0.000274	0.00129	CcSEcCtD
Isoflurane—CALM1—Innate Immune System—SRC—urinary bladder cancer	2.17e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—TYMS—urinary bladder cancer	2.17e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—TYMS—urinary bladder cancer	2.17e-05	0.000119	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—SRC—urinary bladder cancer	2.16e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—SRC—urinary bladder cancer	2.16e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—GSTM1—urinary bladder cancer	2.15e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—NCOR1—urinary bladder cancer	2.15e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—GSTM1—urinary bladder cancer	2.15e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—NCOR1—urinary bladder cancer	2.15e-05	0.000117	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.14e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM3—Disease—FGFR3—urinary bladder cancer	2.14e-05	0.000117	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.14e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—GPX1—urinary bladder cancer	2.12e-05	0.000116	CbGpPWpGaD
Isoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.12e-05	0.000116	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.1e-05	0.000115	CbGpPWpGaD
Isoflurane—ALB—Metabolism—GSTP1—urinary bladder cancer	2.09e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—SRC—urinary bladder cancer	2.09e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—SRC—urinary bladder cancer	2.09e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM2—Disease—FGFR3—urinary bladder cancer	2.07e-05	0.000113	CbGpPWpGaD
Isoflurane—CALM1—Disease—FGFR3—urinary bladder cancer	2.07e-05	0.000113	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—KRAS—urinary bladder cancer	2.07e-05	0.000113	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—S100B—urinary bladder cancer	2.06e-05	0.000113	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—GPX1—urinary bladder cancer	2.06e-05	0.000112	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—GPX1—urinary bladder cancer	2.06e-05	0.000112	CbGpPWpGaD
Isoflurane—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.02e-05	0.000111	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—ERCC2—urinary bladder cancer	2.02e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—ERCC2—urinary bladder cancer	2.02e-05	0.00011	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.01e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—KRAS—urinary bladder cancer	2e-05	0.000109	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—KRAS—urinary bladder cancer	2e-05	0.000109	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—S100B—urinary bladder cancer	2e-05	0.000109	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—S100B—urinary bladder cancer	2e-05	0.000109	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CREBBP—urinary bladder cancer	1.98e-05	0.000108	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.97e-05	0.000108	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—EGFR—urinary bladder cancer	1.97e-05	0.000108	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CDH1—urinary bladder cancer	1.96e-05	0.000107	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000107	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—RHOA—urinary bladder cancer	1.96e-05	0.000107	CbGpPWpGaD
Isoflurane—ALB—Metabolism—TYMS—urinary bladder cancer	1.94e-05	0.000106	CbGpPWpGaD
Isoflurane—ALB—Metabolism—GSTM1—urinary bladder cancer	1.92e-05	0.000105	CbGpPWpGaD
Isoflurane—ALB—Metabolism—NCOR1—urinary bladder cancer	1.92e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CREBBP—urinary bladder cancer	1.91e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CREBBP—urinary bladder cancer	1.91e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—EGFR—urinary bladder cancer	1.9e-05	0.000104	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—EGFR—urinary bladder cancer	1.9e-05	0.000104	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CDH1—urinary bladder cancer	1.9e-05	0.000104	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CDH1—urinary bladder cancer	1.9e-05	0.000104	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—MTHFR—urinary bladder cancer	1.9e-05	0.000104	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—MTHFR—urinary bladder cancer	1.9e-05	0.000104	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—RHOA—urinary bladder cancer	1.89e-05	0.000103	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—RHOA—urinary bladder cancer	1.89e-05	0.000103	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—EGFR—urinary bladder cancer	1.89e-05	0.000103	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—KRAS—urinary bladder cancer	1.86e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NCOR1—urinary bladder cancer	1.86e-05	0.000101	CbGpPWpGaD
Isoflurane—ALB—Metabolism—GPX1—urinary bladder cancer	1.84e-05	0.000101	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—TP53—urinary bladder cancer	1.84e-05	0.0001	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—EGFR—urinary bladder cancer	1.83e-05	0.0001	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—EGFR—urinary bladder cancer	1.83e-05	0.0001	CbGpPWpGaD
Isoflurane—CALM3—Disease—CREBBP—urinary bladder cancer	1.82e-05	9.98e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	9.87e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—KRAS—urinary bladder cancer	1.8e-05	9.84e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—KRAS—urinary bladder cancer	1.8e-05	9.84e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NCOR1—urinary bladder cancer	1.79e-05	9.82e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NCOR1—urinary bladder cancer	1.79e-05	9.82e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—KRAS—urinary bladder cancer	1.79e-05	9.77e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—KRAS—urinary bladder cancer	1.79e-05	9.77e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—TP53—urinary bladder cancer	1.78e-05	9.71e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—TP53—urinary bladder cancer	1.78e-05	9.71e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CREBBP—urinary bladder cancer	1.76e-05	9.65e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CREBBP—urinary bladder cancer	1.76e-05	9.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—HRAS—urinary bladder cancer	1.76e-05	9.6e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—KRAS—urinary bladder cancer	1.73e-05	9.45e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—KRAS—urinary bladder cancer	1.73e-05	9.45e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—CXCL8—urinary bladder cancer	1.72e-05	9.39e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—HRAS—urinary bladder cancer	1.7e-05	9.29e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—HRAS—urinary bladder cancer	1.7e-05	9.29e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—MTHFR—urinary bladder cancer	1.7e-05	9.28e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.66e-05	9.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.66e-05	9.08e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—ERBB2—urinary bladder cancer	1.65e-05	9.05e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—RHOA—urinary bladder cancer	1.65e-05	9.02e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—IL2—urinary bladder cancer	1.64e-05	8.98e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TERT—urinary bladder cancer	1.63e-05	8.94e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.63e-05	8.94e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—ERBB2—urinary bladder cancer	1.6e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—ERBB2—urinary bladder cancer	1.6e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.6e-05	8.75e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—RHOA—urinary bladder cancer	1.6e-05	8.73e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—RHOA—urinary bladder cancer	1.6e-05	8.73e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PPARG—urinary bladder cancer	1.59e-05	8.7e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—TP53—urinary bladder cancer	1.59e-05	8.69e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—IL2—urinary bladder cancer	1.59e-05	8.68e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—IL2—urinary bladder cancer	1.59e-05	8.68e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TERT—urinary bladder cancer	1.58e-05	8.65e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TERT—urinary bladder cancer	1.58e-05	8.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—HRAS—urinary bladder cancer	1.58e-05	8.65e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.57e-05	8.58e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PPARG—urinary bladder cancer	1.54e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PPARG—urinary bladder cancer	1.54e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.54e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—HRAS—urinary bladder cancer	1.53e-05	8.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—HRAS—urinary bladder cancer	1.53e-05	8.36e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	8.35e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—ERBB2—urinary bladder cancer	1.53e-05	8.35e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—HRAS—urinary bladder cancer	1.52e-05	8.31e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—HRAS—urinary bladder cancer	1.52e-05	8.3e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—FGFR3—urinary bladder cancer	1.5e-05	8.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IL2—urinary bladder cancer	1.5e-05	8.2e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PTGS2—urinary bladder cancer	1.49e-05	8.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—CREBBP—urinary bladder cancer	1.48e-05	8.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—CREBBP—urinary bladder cancer	1.48e-05	8.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—ERBB2—urinary bladder cancer	1.48e-05	8.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—ERBB2—urinary bladder cancer	1.48e-05	8.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—HRAS—urinary bladder cancer	1.47e-05	8.03e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—HRAS—urinary bladder cancer	1.47e-05	8.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ESR1—urinary bladder cancer	1.46e-05	7.97e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—FGFR3—urinary bladder cancer	1.45e-05	7.94e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—FGFR3—urinary bladder cancer	1.45e-05	7.94e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IL2—urinary bladder cancer	1.45e-05	7.93e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IL2—urinary bladder cancer	1.45e-05	7.93e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PTGS2—urinary bladder cancer	1.44e-05	7.9e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PTGS2—urinary bladder cancer	1.44e-05	7.9e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CDKN1A—urinary bladder cancer	1.41e-05	7.73e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—PTEN—urinary bladder cancer	1.41e-05	7.72e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ESR1—urinary bladder cancer	1.41e-05	7.71e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ESR1—urinary bladder cancer	1.41e-05	7.71e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PPARG—urinary bladder cancer	1.38e-05	7.52e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CDKN1A—urinary bladder cancer	1.37e-05	7.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CDKN1A—urinary bladder cancer	1.37e-05	7.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PTEN—urinary bladder cancer	1.36e-05	7.46e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PTEN—urinary bladder cancer	1.36e-05	7.46e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—EP300—urinary bladder cancer	1.35e-05	7.36e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	7.23e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—SRC—urinary bladder cancer	1.31e-05	7.16e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CDKN1A—urinary bladder cancer	1.31e-05	7.14e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PTEN—urinary bladder cancer	1.3e-05	7.12e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—EP300—urinary bladder cancer	1.3e-05	7.12e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—EP300—urinary bladder cancer	1.3e-05	7.12e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.29e-05	7.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CREBBP—urinary bladder cancer	1.28e-05	6.99e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—SRC—urinary bladder cancer	1.27e-05	6.92e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—SRC—urinary bladder cancer	1.27e-05	6.92e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CDKN1A—urinary bladder cancer	1.26e-05	6.91e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CDKN1A—urinary bladder cancer	1.26e-05	6.91e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IGF1—urinary bladder cancer	1.26e-05	6.9e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PTEN—urinary bladder cancer	1.26e-05	6.89e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PTEN—urinary bladder cancer	1.26e-05	6.89e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	6.88e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—EGFR—urinary bladder cancer	1.25e-05	6.86e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	6.84e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—EP300—urinary bladder cancer	1.24e-05	6.79e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CREBBP—urinary bladder cancer	1.24e-05	6.76e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CREBBP—urinary bladder cancer	1.24e-05	6.76e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IGF1—urinary bladder cancer	1.22e-05	6.67e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IGF1—urinary bladder cancer	1.22e-05	6.67e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—EGFR—urinary bladder cancer	1.21e-05	6.64e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—EGFR—urinary bladder cancer	1.21e-05	6.64e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTGS2—urinary bladder cancer	1.21e-05	6.62e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTGS2—urinary bladder cancer	1.21e-05	6.62e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—SRC—urinary bladder cancer	1.21e-05	6.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—EP300—urinary bladder cancer	1.2e-05	6.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—EP300—urinary bladder cancer	1.2e-05	6.57e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—KRAS—urinary bladder cancer	1.19e-05	6.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—SRC—urinary bladder cancer	1.17e-05	6.39e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—SRC—urinary bladder cancer	1.17e-05	6.39e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—RHOA—urinary bladder cancer	1.16e-05	6.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—KRAS—urinary bladder cancer	1.15e-05	6.27e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—KRAS—urinary bladder cancer	1.15e-05	6.27e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—EGFR—urinary bladder cancer	1.15e-05	6.27e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.12e-05	6.13e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—RHOA—urinary bladder cancer	1.12e-05	6.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—RHOA—urinary bladder cancer	1.12e-05	6.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—EGFR—urinary bladder cancer	1.11e-05	6.07e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—EGFR—urinary bladder cancer	1.11e-05	6.07e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.1e-05	6e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTEN—urinary bladder cancer	1.09e-05	5.97e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—KRAS—urinary bladder cancer	1.08e-05	5.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MYC—urinary bladder cancer	1.08e-05	5.92e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	5.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ERBB2—urinary bladder cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—EGFR—urinary bladder cancer	1.06e-05	5.79e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTEN—urinary bladder cancer	1.06e-05	5.77e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTEN—urinary bladder cancer	1.06e-05	5.77e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—KRAS—urinary bladder cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—KRAS—urinary bladder cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MYC—urinary bladder cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MYC—urinary bladder cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.05e-05	5.73e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—EP300—urinary bladder cancer	1.04e-05	5.69e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ERBB2—urinary bladder cancer	1.03e-05	5.66e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ERBB2—urinary bladder cancer	1.03e-05	5.66e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—EGFR—urinary bladder cancer	1.02e-05	5.6e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—EGFR—urinary bladder cancer	1.02e-05	5.6e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CXCL8—urinary bladder cancer	1.01e-05	5.55e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—HRAS—urinary bladder cancer	1.01e-05	5.51e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—EP300—urinary bladder cancer	1.01e-05	5.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—EP300—urinary bladder cancer	1.01e-05	5.5e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—KRAS—urinary bladder cancer	1e-05	5.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CXCL8—urinary bladder cancer	9.81e-06	5.37e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CXCL8—urinary bladder cancer	9.81e-06	5.37e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—HRAS—urinary bladder cancer	9.75e-06	5.33e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—HRAS—urinary bladder cancer	9.75e-06	5.33e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IL2—urinary bladder cancer	9.69e-06	5.3e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—KRAS—urinary bladder cancer	9.67e-06	5.29e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—KRAS—urinary bladder cancer	9.67e-06	5.29e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CCND1—urinary bladder cancer	9.45e-06	5.17e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTEN—urinary bladder cancer	9.43e-06	5.16e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IL2—urinary bladder cancer	9.38e-06	5.13e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IL2—urinary bladder cancer	9.38e-06	5.13e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—HRAS—urinary bladder cancer	9.21e-06	5.04e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MMP9—urinary bladder cancer	9.17e-06	5.02e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CDKN1A—urinary bladder cancer	9.14e-06	5e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CCND1—urinary bladder cancer	9.14e-06	5e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CCND1—urinary bladder cancer	9.14e-06	5e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PTEN—urinary bladder cancer	9.12e-06	4.99e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—EP300—urinary bladder cancer	9e-06	4.92e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—HRAS—urinary bladder cancer	8.91e-06	4.87e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—HRAS—urinary bladder cancer	8.91e-06	4.87e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MMP9—urinary bladder cancer	8.87e-06	4.85e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MMP9—urinary bladder cancer	8.87e-06	4.85e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CDKN1A—urinary bladder cancer	8.84e-06	4.84e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.84e-06	4.84e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PTEN—urinary bladder cancer	8.82e-06	4.83e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PTEN—urinary bladder cancer	8.82e-06	4.83e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EP300—urinary bladder cancer	8.7e-06	4.76e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—HRAS—urinary bladder cancer	8.5e-06	4.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SRC—urinary bladder cancer	8.46e-06	4.63e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EP300—urinary bladder cancer	8.41e-06	4.6e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EP300—urinary bladder cancer	8.41e-06	4.6e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—HRAS—urinary bladder cancer	8.22e-06	4.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—HRAS—urinary bladder cancer	8.22e-06	4.5e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SRC—urinary bladder cancer	8.18e-06	4.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SRC—urinary bladder cancer	8.18e-06	4.48e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MYC—urinary bladder cancer	7.58e-06	4.15e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EGFR—urinary bladder cancer	7.41e-06	4.05e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MYC—urinary bladder cancer	7.33e-06	4.01e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MYC—urinary bladder cancer	7.33e-06	4.01e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EGFR—urinary bladder cancer	7.17e-06	3.92e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EGFR—urinary bladder cancer	7.17e-06	3.92e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KRAS—urinary bladder cancer	7e-06	3.83e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KRAS—urinary bladder cancer	6.77e-06	3.71e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KRAS—urinary bladder cancer	6.77e-06	3.71e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TP53—urinary bladder cancer	6.22e-06	3.4e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TP53—urinary bladder cancer	6.02e-06	3.29e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TP53—urinary bladder cancer	6.02e-06	3.29e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—HRAS—urinary bladder cancer	5.95e-06	3.26e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—HRAS—urinary bladder cancer	5.76e-06	3.15e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—HRAS—urinary bladder cancer	5.76e-06	3.15e-05	CbGpPWpGaD
